Ira Duarte

Ira Duarte

Director of Finance/CFO at HERON THERAPEUTICS, INC.

Net worth: 557 555 $ as of 30/06/2026

57 year
Health Technology
Consumer Services
Commercial Services

Profile

Ira Duarte is currently an Independent Director at Terrascend Corp.
since 2022 and EVP, Chief Financial & Accounting Officer at Heron Therapeutics, Inc. starting in 2024.
Former positions include Chief Financial Officer & VP-Controller at Veloxis Pharmaceuticals A from 2018 to 2023, Controller at BioDelivery Sciences International, Inc. from 2014 to 2016, Director-Accounting & Financial Planning at Chiesi USA, Inc. from 2009 to 2013, and Senior Manager at Ernst & Young A. Education includes undergraduate studies at Florida Atlantic University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/06/2026 657,930 ( 0.21% ) 446 077 $ 30/06/2026
16/06/2026 261,073 ( 0.14% ) 111 478 $ 30/06/2026

Ira Duarte active positions

CompaniesPositionStart
TERRASCEND CORP. Director/Board Member 02/12/2022
HERON THERAPEUTICS, INC. Director of Finance/CFO 16/06/2023

Former positions of Ira Duarte

CompaniesPositionEnd
VELOXIS PHARMACEUTICALS A/S Director of Finance/CFO 01/01/2023
BIODELIVERY SCIENCES INTERNATIONAL, INC. Comptroller/Controller/Auditor 01/01/2016
CORNERSTONE THERAPEUTICS, INC. Comptroller/Controller/Auditor 01/10/2013
Corporate Officer/Principal -
See the detail of Ira Duarte's experience

Training of Ira Duarte

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Process Industries